UCI de Trauma y Emergencias, Servicio de Medicina Intensiva, Hospital Universitario 12 de Octubre, Madrid, Spain.
Servei de Medicina Intensiva, Hospital Universitari Son Espases, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain.
Am Surg. 2021 Mar;87(3):370-375. doi: 10.1177/0003134820949990. Epub 2020 Sep 29.
To compare the main outcomes of trauma patients with and without traumatic brain injury (TBI), hemorrhagic shock, and the combination of both using data from the Spanish trauma intensive care unit (ICU) registry (RETRAUCI).
Patients admitted to the participating ICUs from March 2015 to May 2019 were included in the study. The main outcomes were analyzed according to the presence of TBI, hemorrhagic shock, and/or both. Comparison of groups with quantitative variables was performed using the Kruskal-Wallis test, and differences between groups with categorical variables were compared using the Chi-square test or Fisher's exact test as appropriate. A value <.05 was considered significant.
Overall, 310 patients (3.98%) were presented with TBI and hemorrhagic shock. Patients with TBI and hemorrhagic shock received more red blood cell (RBC) concentrates, fresh frozen plasma (FFP), a higher ratio FFP/RBC, and had a higher incidence of trauma-induced coagulopathy (60%) ( < .001). These patients had higher mortality ( < .001). Intracranial hypertension was the leading cause of death (50.4%).
Concomitant TBI and hemorrhagic shock occur in nearly 4% of trauma ICU patients. These patients required a higher amount of RBC concentrates and FFP and had an increased mortality.
为了比较创伤患者伴有和不伴有创伤性脑损伤(TBI)、失血性休克以及两者同时存在的主要结局,使用来自西班牙创伤重症监护病房(ICU)登记处(RETRAUCI)的数据进行了此项研究。
纳入了 2015 年 3 月至 2019 年 5 月期间入住参与 ICU 的患者。主要结局根据是否存在 TBI、失血性休克和/或两者进行分析。使用 Kruskal-Wallis 检验比较定量变量组间差异,使用卡方检验或 Fisher 确切概率法比较分类变量组间差异,以 P 值<.05 为差异有统计学意义。
总体而言,310 例(3.98%)患者表现为 TBI 和失血性休克。伴有 TBI 和失血性休克的患者输注了更多的红细胞(RBC)浓缩物、新鲜冷冻血浆(FFP),FFP/RBC 比值更高,且创伤性凝血病的发生率更高(60%)(<0.001)。这些患者的死亡率更高(<0.001)。颅内高压是导致死亡的主要原因(50.4%)。
近 4%的创伤 ICU 患者同时存在 TBI 和失血性休克。这些患者需要输注更多的 RBC 浓缩物和 FFP,且死亡率更高。